{
    "2020-12-10": [
        [
            {
                "time": "2020-12-10",
                "original_text": "Lilly's (LLY) Tirzepatide Meets Endpoints in Late-Stage Study",
                "features": {
                    "keywords": [
                        "Tirzepatide",
                        "Endpoints",
                        "Late-Stage",
                        "Study"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-12-10",
                "original_text": "Thiel-backed antibody therapy developer AbCellera boosts IPO price range",
                "features": {
                    "keywords": [
                        "Thiel-backed",
                        "antibody",
                        "therapy",
                        "developer",
                        "AbCellera",
                        "IPO",
                        "price",
                        "range"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-12-10",
                "original_text": "Eli Lilly (LLY) Soars: Stock Adds 5.8% in Session",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Soars",
                        "Stock",
                        "Adds",
                        "5.8%",
                        "Session"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}